World News

UK becomes first country to approve anti-Covid pill

By Jasleen Kaur -- November 05, 2021 4:11 pm -- Updated:Feb 15, 2021

The United Kingdom (UK) has approved first oral tablet for the treatment of symptomatic Covid-19 patients. It was given approval over the weekend. As per clinical trials, the pill named Molnupiravir has reportedly cut down hospitalisations by half.

The pill has been developed by US drug manufacturer Merck, Sharp and Dohme (MSD) and Ridgeback Biotheraputics. Molnupiravir is neither injected nor given intravenously. It is a pill that is taken orally.

Molnupiravir: long-term safety questions linger as approvals approach

Also read | Fuel price update: These states have further reduced rates; check list

As far as dosage is concerned, the tablet is given twice a day to vulnerable patients, who are Covid-positive and have symptoms. The pill is to be given within five days of the onset of infection.

A new oral antiviral drug for Covid is being tested in humans – can it make a difference?

Also read | Cricket fraternity extends greetings as Virat Kohli turns 33

It reportedly targets an enzyme that the virus uses to make copies of it. This creates a genetic code that prevents it from multiplying in numbers. The pill helps in keeping both the virus and the severity levels in check.

COVID-19: Everest Organics starts making ingredient for Merck's molnupiravir drug - BusinessToday

The country has about 40,000 daily cases of Covid-19, according to the latest report.
-PTC News